Revance Therapeutics
RVNC
HK$28.41
Share price
0.00%
Change (1 day)
-19.54%
Change (1 year)
Categories
Revance Therapeutics (RVNC) - Cash on Hand
Cash on Hand as of September 2024 : HK$1.43 Billion
According to Revance Therapeutics's latest financial reports the company has HK$1.43 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Revance Therapeutics - Cash on Hand chart (from 2012 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | HK$1.98 B | -25.5% |
| 2022-12-31 | HK$2.66 B | 51.68% |
| 2021-12-31 | HK$1.75 B | -48.14% |
| 2020-12-31 | HK$3.38 B | 49.77% |
| 2019-12-31 | HK$2.25 B | 64.11% |
| 2018-12-31 | HK$1.37 B | -37.71% |
| 2017-12-31 | HK$2.21 B | 53.63% |
| 2016-12-31 | HK$1.43 B | -26.43% |
| 2015-12-31 | HK$1.95 B | 47.41% |
| 2014-12-31 | HK$1.32 B | 4270.94% |
| 2013-12-31 | HK$30.35 M | -4.1% |
| 2012-12-31 | HK$31.64 M | -86.24% |
| 2011-12-31 | HK$0.23 B |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | HK$0.31 B | -78.07% | 🇺🇸 USA |
 | HK$190.84 B | 13,221.67% | 🇺🇸 USA |
 | HK$18.48 B | 1,190.23% | 🇺🇸 USA |